RAS oncogenes: the first 30 years - PubMed (original) (raw)
Review
doi: 10.1038/nrc1097.
Affiliations
- PMID: 12778136
- DOI: 10.1038/nrc1097
Review
RAS oncogenes: the first 30 years
Marcos Malumbres et al. Nat Rev Cancer. 2003 Jun.
Erratum in
- Nat Rev Cancer. 2003 Sep;3(9):708
Abstract
From the pioneering work with acute transforming retroviruses to the current post-genomic era, RAS genes have always been at the leading edge of signal transduction and molecular oncology. Yet, a complete understanding of RAS function and dysfunction - mainly in human cancer - is still to come. The knowledge that has accumulated since their discovery 30 years ago has, however, been remarkable, and should pave the way for not only solving the outstanding issues regarding RAS biology, but also for developing efficacious drugs that could have a significant impact on cancer treatment.
Similar articles
- [Armand Tavitian (1931-2020): from oncogenes to the Ras superfamily].
Moreau-Gachelin F, Camonis J, de Gunzburg J, Goud B. Moreau-Gachelin F, et al. Med Sci (Paris). 2020 Aug-Sep;36(8-9):810-812. doi: 10.1051/medsci/2020136. Epub 2020 Aug 21. Med Sci (Paris). 2020. PMID: 32821056 French. No abstract available. - A perspective on the early days of RAS research.
Weiss RA. Weiss RA. Cancer Metastasis Rev. 2020 Dec;39(4):1023-1028. doi: 10.1007/s10555-020-09919-1. Epub 2020 Jul 29. Cancer Metastasis Rev. 2020. PMID: 32728828 Free PMC article. Review. - [The first 20 years of the Department of Molecular Genetics of the National Institute of Oncology (NIO)].
Oláh E. Oláh E. Magy Onkol. 2007;51(2):89-94. Epub 2007 Jul 29. Magy Onkol. 2007. PMID: 17660864 Hungarian. - 30 years and a long way into p53 research.
Hainaut P, Wiman KG. Hainaut P, et al. Lancet Oncol. 2009 Sep;10(9):913-9. doi: 10.1016/S1470-2045(09)70198-6. Lancet Oncol. 2009. PMID: 19717093 - 40 Years of RAS-A Historic Overview.
Fernández-Medarde A, De Las Rivas J, Santos E. Fernández-Medarde A, et al. Genes (Basel). 2021 May 1;12(5):681. doi: 10.3390/genes12050681. Genes (Basel). 2021. PMID: 34062774 Free PMC article. Review.
Cited by
- Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.
Alonso S, Dai Y, Yamashita K, Horiuchi S, Dai T, Matsunaga A, Sánchez-Muñoz R, Bilbao-Sieyro C, Díaz-Chico JC, Chernov AV, Strongin AY, Perucho M. Alonso S, et al. Oncotarget. 2015 Feb 20;6(5):3420-31. doi: 10.18632/oncotarget.2852. Oncotarget. 2015. PMID: 25638164 Free PMC article. - The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.
Ouerhani S, Bougatef K, Soltani I, Elgaaied AB, Abbes S, Menif S. Ouerhani S, et al. Mol Biol Rep. 2013 Jun;40(6):4109-14. doi: 10.1007/s11033-013-2512-8. Epub 2013 May 3. Mol Biol Rep. 2013. PMID: 23640097 - Pathogenesis of central nervous system germ cell tumors.
Liu S, Ren L, Gao X, Hao M, Wang G. Liu S, et al. Front Oncol. 2022 Sep 9;12:991484. doi: 10.3389/fonc.2022.991484. eCollection 2022. Front Oncol. 2022. PMID: 36158643 Free PMC article. Review. - The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Guin S, Theodorescu D. Guin S, et al. Acta Pharmacol Sin. 2015 Mar;36(3):291-7. doi: 10.1038/aps.2014.129. Epub 2015 Jan 5. Acta Pharmacol Sin. 2015. PMID: 25557115 Free PMC article. Review. - Integrative analysis of cancer-related signaling pathways.
Kessler T, Hache H, Wierling C. Kessler T, et al. Front Physiol. 2013 Jun 4;4:124. doi: 10.3389/fphys.2013.00124. eCollection 2013. Front Physiol. 2013. PMID: 23760067 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources